Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Painless Diabetes Patch to Replace Needle Pricks

By HospiMedica International staff writers
Posted on 24 Mar 2025

A painless patch that continuously sends a person’s health status to their phone could lead to the commercialization of a healthcare breakthrough for continuous monitoring of blood glucose, ketone, lactate, and more. More...

Researchers at the University of Waterloo (Waterloo, ON, Canada) have developed small, mini patches, smaller than a typical band-aid, that allow continuous monitoring of blood glucose and ketone levels for individuals with Type 1 diabetes, providing real-time data directly to their smartphones or healthcare providers. This innovation could eliminate the need for the painful, invasive needle pricks currently used to monitor these levels. The technology is particularly critical for Type 1 diabetes patients, who need to monitor both blood glucose and ketone levels. As no continuous ketone monitoring device is currently available, these patches could help reduce the risk of diabetic ketoacidosis, a potentially life-threatening condition caused by elevated ketone levels, by alerting patients when their levels are dangerously high. After successfully validating the patches in animal models, the research team has begun human testing using non-diabetic adults who were asked to take a ketone supplement for effective monitoring. The next phase will involve further validation in diabetic patients, in collaboration with clinical partners.

In addition to their use in diabetes care, the patches are also being developed for continuous monitoring of other conditions, including cardiovascular disease and lactate levels. The team has also created a patch designed for continuous lactate monitoring, utilizing Aptamer probes—special probes made of DNA that can be customized to target any molecule. This overcomes the limitations of enzyme-based sensors, such as those used in current continuous glucose monitors, which are restricted to specific targets with available enzymes. After the successful validation of the Aptamer on animal models, the team has moved forward with human trials for continuous lactate monitoring. This could be particularly beneficial for athletes who need to ensure they are exercising at their optimal condition. Currently, athletes must stop their workout to measure blood lactate levels, which may not represent their real-time lactate levels during exercise. These wearable Aptamer sensors will allow continuous lactate monitoring throughout their workout, providing more accurate and timely data.

“What distinguishes our patches from solid needles is that they are fully painless and compatible with the skin … they’re made out of hydrogels” said Dr. Mahla Poudineh, professor in the Department of Electrical and Computer Engineering. “These patches are solid before skin penetration, but upon insertion they start swelling by absorbing the fluid underneath the skin, which would make them flexible and quite compatible with the skin.”

Related Links:
University of Waterloo


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Medical Adhesive
MED 5570U
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.